AEHR stock forecast, quote, news & analysis
Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits... Show more
Why Aehr Test Systems (AEHR) Stock Is Down -33% in the Last 30 Days
Key Takeaways
- Aehr Test Systems (AEHR) shares fell approximately 33% over the last 30 days, declining from $108.47 on June 12 to $72.61 by July 10, 2026.
- The steepest single-session drop occurred on July 2, when the stock plunged roughly 17% amid heavy insider selling disclosures and post-Russell-index-reconstitution repositioning.
- Removal from a broad slate of Russell indices, including the Russell 3000E and Russell Microcap, on June 27 reduced passive fund demand and amplified negative sentiment.
- Valuation concerns intensified as the stock's market capitalization remained above $2.2 billion despite quarterly revenue of just $10.3 million and ongoing net losses.
- Robust AI-related order flow and record backlog have not yet translated into improved quarterly financials, creating a disconnect between business momentum and near-term results.
- Upcoming fiscal Q4 2026 earnings, expected around July 14, represent a critical catalyst for the stock's next direction.
Aehr Test Systems (AEHR) Company Overview and Market Position
Aehr Test Systems develops, manufactures, and sells semiconductor test and burn-in equipment used by device manufacturers to ensure the quality and reliability of integrated circuits. Headquartered in Fremont, California, the company's product portfolio includes the FOX-XP and FOX-NP wafer-level test and burn-in systems, the FOX-CP compact single-wafer test solution, and Sonoma packaged-part burn-in systems. Aehr's technology addresses critical testing needs for silicon carbide (SiC) power semiconductors, silicon photonics transceivers, gallium nitride (GaN) devices, AI processors, and memory chips. The company has positioned itself as a leader in wafer-level burn-in for silicon photonics and has deployed its FOX systems to more than 25 customers worldwide. The recent acquisition of Incal Technology expanded Aehr's capabilities into package-level reliability and burn-in testing, broadening its addressable market in AI semiconductor manufacturing.
Aehr Test Systems (AEHR) Stock Price Performance: Last 30 Days vs. Quarter
Over the trailing 30-day period, AEHR shares declined roughly 33%, falling from a closing price of $108.47 on June 12, 2026, to $72.61 on July 10, 2026. The stock reached an all-time high of $126.62 during intraday trading on June 15 before a sharp reversal took hold. The selloff accelerated in early July following the Russell index reconstitution and a cluster of insider transaction filings. During the broader quarter, AEHR experienced extraordinary volatility. The stock posted a 52-week gain exceeding 400% at its June peak, driven by a series of high-profile AI-related orders. However, the quarterly trend ultimately reflects a boom-and-bust pattern: a massive rally that peaked in mid-June, followed by a rapid unwind that erased a significant portion of those gains. The 200-day moving average of $55.84 and the 50-day moving average of approximately $98 highlight how dramatically the stock overshot its longer-term trend before correcting.
What Drove AEHR Stock Price in the Last 30 Days
Several converging factors drove the 33% decline in AEHR shares over the last 30 days. The most impactful catalyst was the stock's removal from a broad family of Russell indices on June 27, 2026, including the Russell 3000E, Russell Microcap, and related value and growth benchmarks. This sweeping exit reduced passive fund ownership and triggered repositioning by quantitative strategies and liquidity-sensitive institutional investors. The removal acted as an amplifier of pre-existing concerns rather than a standalone fundamental problem. On July 2, disclosure of 14 insider transactions—including significant stock sales by directors and executives—further rattled investor confidence, contributing to a single-day drop of approximately 17%. Additionally, valuation anxiety mounted as AEHR's market capitalization remained above $2.2 billion despite generating only $10.3 million in quarterly revenue and posting a non-GAAP net loss. With a forward price-to-sales ratio exceeding 40x, well above the company's three-year historical average of approximately 10x, the stock became vulnerable to a sharp mean-reversion trade. Broader market rotation away from high-multiple, pre-profit semiconductor names compounded the selling pressure.
What Drove AEHR Stock Performance Over the Last Quarter
The broader quarterly narrative for AEHR is defined by a dramatic rally followed by a steep correction. The stock surged to its all-time high of $126.62 on June 15, fueled by a string of announced orders: a record $41 million follow-on production order from a lead hyperscale customer in mid-April for Sonoma package-level burn-in systems, and a June 17 follow-on order for a fully automated FOX-XP wafer-level burn-in system from a major silicon photonics customer supplying the data center optical transceiver market. Bookings momentum reached record levels in fiscal Q3, with $37.2 million in orders and an effective backlog exceeding $50 million. However, the company's quarterly financial results showed a 44% year-over-year revenue decline to $10.3 million, a non-GAAP net loss, and gross margin compression. The disconnect between strong bookings and weak current financials created a fragile valuation setup. Once the Russell index removal and insider selling triggered the initial decline, profit-taking accelerated and the stock gave back months of gains in a matter of weeks.
Trending AI Robots
Navigating volatile stocks like Aehr Test Systems requires timely data and disciplined strategy. Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots drawn from a universe of hundreds of automated strategies that trade thousands of tickers. Only the top-performing and most relevant bots appear in this section, with each bot varying in strategy, timeframe, and risk profile. Whether you are interested in short-term momentum plays or longer-duration trend-following approaches, the Trending AI Robots page provides a real-time window into which automated strategies are currently generating results. Browse the selection to see how AI-driven trading can help identify opportunities in stocks like AEHR and beyond.
AEHR Stock Forecast Drivers: What Investors Should Watch Next
The most immediate catalyst for AEHR is the company's fiscal Q4 2026 earnings report, expected around July 14, 2026. Investors will scrutinize whether record bookings translate into revenue acceleration, whether gross margins stabilize or improve, and whether management reaffirms the path back to non-GAAP profitability. The effective backlog of over $50 million and management's guidance for second-half bookings at the high end of $60–$80 million suggest meaningful revenue growth may materialize in fiscal 2027, but the timing and pace of conversion remain uncertain. Beyond earnings, key factors to monitor include additional order announcements—particularly from AI processor and silicon photonics customers—capacity expansion progress, and any further insider transaction activity. On the macroeconomic front, semiconductor equipment demand trends, data center capital expenditure cycles, and potential tariff developments remain relevant. Analyst consensus currently rates the stock a Buy with an average price target near $71, though individual targets range widely from $56 to $90, reflecting the high degree of uncertainty around Aehr's near-term execution and valuation.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
AEHR in downward trend: 10-day moving average broke below 50-day moving average on July 02, 2026
The 10-day moving average for AEHR crossed bearishly below the 50-day moving average on July 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on June 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
AEHR moved below its 50-day moving average on June 26, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for AEHR entered a downward trend on July 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 55 cases where AEHR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on July 16, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in of 35 cases over the following month. The odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .
AEHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (12.453) is normal, around the industry mean (9.408). P/E Ratio (19.449) is within average values for comparable stocks, (90.203). AEHR's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.744). AEHR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.006). P/S Ratio (51.546) is also within normal values, averaging (95.882).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment